低强度脉冲超声(LIPUS)对比手术治疗上下肢骨不连的疗效:PiNGUin 全国性前瞻性随机对照开放标签多中心非劣效性研究方案
PiNGUin 是一项为期五年的全国性、前瞻性、随机、对照、开放标签、多中心医疗器械研究,比较每日 20 分钟 LIPUS 治疗 200 天与标准手术干预对上下肢骨不连的疗效。主要终点为治疗开始后 12 个月骨折愈合(至少 3/4 皮质骨性愈合及功能恢复),非劣效界值为 -25 个百分点。按单侧显著性水平 2.5%、把握度 90%、假设脱落率 10% 计算,每组需 184 例患者。
要点
- 骨不连定义为至少 6 个月未愈合的骨折,发生于所有骨折的 2-10%,特定危险因素患者中高达 30%。
- LIPUS 为低风险操作,仅极少数患者出现皮肤反应,患者可在家独立使用,免去反复就医。
- 研究旨在证明 LIPUS 在上下肢骨不连骨折愈合方面不劣于手术干预,非劣效界值为 -25 个百分点。
核心结论
- 本研究旨在证明 LIPUS 治疗在上下肢骨不连的骨折愈合方面不劣于手术干预,非劣效界值为 -25 个百分点。
- 若证实非劣效,未来患者将可选择侵入性或非侵入性治疗。
研究设计与样本
- PiNGUin 为为期五年的全国性、前瞻性、对照、随机、开放标签、多中心医疗器械研究。
- 患者随机分为两组:干预组接受每日 20 分钟 LIPUS 治疗 200 天,对照组接受标准手术干预。
- 两组随访均为 12 个月。
- 按单侧显著性水平 2.5%、把握度 90%、假设脱落率 10% 计算,每组需 184 例患者。
主要发现
- 主要终点为治疗开始后 12 个月骨折愈合,定义为至少 3/4 皮质骨性愈合及功能恢复。
- 次要终点包括骨折愈合时间、完全负重时间、疼痛发生率和强度、功能主诉/日常生活活动、健康相关生活质量、并发症、不良事件、再手术或再内固定、(再)住院、住院时间、无法工作的时长和原因。
关键数值与推荐
- 非劣效界值为 -25 个百分点。
- 单侧显著性水平为 2.5%,把握度为 90%,假设脱落率为 10%。
- 每组所需样本量为 184 例患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-unions, defined as fractures not healed after at least 6 months, are a multifactorial complication occurring in 2-10% of all fractures and in up to 30% of patients with certain risk factors. Treatment costs are markedly higher than those associated with normal fracture healing and patients often suffer from pain and loss of function. Surgical revision is the gold standard for treatment; however, the disadvantages are re-hospitalization, possible secondary diseases and side effects such as post-operative infections, complications of anesthesia and embolisms. Low-intensity pulsed ultrasound (LIPUS) is a low-risk procedure, with skin reactions being the only side effect experienced by a very small number of patients. Patients can use the treatment independently at home, eliminating the need for repeated hospital visits. This study aims to show that LIPUS treatment is not inferior to surgical intervention by a threshold of -25 percentage points in terms of fracture healing in non-unions of the upper or lower extremity. METHODS: PiNGUin will be a five-year national, prospective, controlled, randomized, open-label, multicenter study with a medical device. Patients are randomized into one of two groups: patients in the intervention group will receive daily 20-min LIPUS treatment for 200 days or undergo standard surgical intervention in the control group. Follow-up for both groups will be 12 months. The primary endpoint is fracture healing 12 months after treatment start, defined as bony consolidation of at least 3 out of 4 cortices and functional recovery. Secondary endpoints include time to fracture healing and to full weight bearing, incidence and intensity of pain, functional complaints/activities of daily living, health-related quality of life, complications, adverse events, re-operations or re-osteosyntheses and (re-) hospitalizations, hospital stays, duration and reasons for inability to work. With a one-sided significance level of 2.5%, a power of 90% and an assumed drop-out rate of 10% 184 patients will be required per treatment group. DISCUSSION: As LIPUS is a low-complication procedure with good results to date, this treatment is considered a potential alternative to surgery. If non-inferiority is proven, patients will have a choice of both invasive and non-invasive procedures in the future. TRIAL REGISTRATION: DRKS00034357 (German Clinical Trials Register, registered March 11th, 2025).
引用
- Steinhausen ES, Stang A, Hüsing A, et al. The effect of low-intensity pulsed ultrasound (LIPUS) for the treatment of upper and lower extremity non-union compared to surgical intervention (PiNGUin): study protocol for a national, prospective, randomized controlled, open-label, multicenter, non-inferiority study. Trials. 2025. PMID: 41146252. doi:10.1186/s13063-025-09212-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。